Search Results 1821-1830 of 16054 for angiogramlet'
This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...
The purpose of this study is to evaluate the cellular composition of PRP produced by the Arthrex Angel System. Participation eligibility. Participant ...
About this study. The purpose of this study is to determine if treatment with androgen deprivation therapy (ADT) plus apalutamide before and after radical ...
The purpose of this study is to assess the safety of mesenchymal stem cells in patients with Interstitial Lung Disease (ILD) associated with Connective Tissue ...
Subjects on GSK2330672 will also receive placebo tablets to maintain blinding. The total duration of a subject's participation will be up to 45 days of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The standard treatment: Doses of the hormone erythropoietin (EPO) to stimulate bone marrow to produce red blood cells, which contain hemoglobin. A red blood ...
The first thing to do when a patient is diagnosed is I tell that patient, this is a scary moment. We understand that. Take a deep breath. As you come to see me ...
The Nov. 16 cover article, “An Injectable Shear-Thinning Biomaterial for Endovascular Embolization,” in the journal Science Translational Medicine reports on a ...
About this study. The researchers are trying to identify molecular mechanisms that control growth plate mediated limb growth and identify agents that can be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.